CV (CapsoVision) Stock Based Compensation: $1.01 Mil (TTM As of Mar. 2026)


CV CapsoVision Inc CV
10 GF Score
Price $7.35
! 1 Warning Sign
View Full Analysis

What is CapsoVision Stock Based Compensation?

CapsoVision CV -2.25% 10 Stock Based Compensation is $1.01 Mil as of Mar. 2026. GuruFocus rates CV with a GF Score™ of 10/100. The stock has 1 warning sign investors should review.

CapsoVision's Stock Based Compensation for the three months ended in Mar. 2026 was $0.33 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was $1.01 Mil.

CapsoVision Stock Based Compensation Related Terms

CapsoVision Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for CapsoVision's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CapsoVision Stock Based Compensation Chart

CapsoVision Annual Data
Trend Dec23 Dec24 Dec25
Stock Based Compensation
0.04 0.16 0.83

CapsoVision Quarterly Data
Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.17 0.31 0.20 0.33
CV
10GF Score
CapsoVision Inc CV
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CapsoVision Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.01 Mil.

What does a Stock Based Compensation of $1.01 Mil mean?
CapsoVision (CV) has a Stock Based Compensation of $1.01 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for CapsoVision and its competitors.
Is CapsoVision's Stock Based Compensation too high?
CapsoVision's current Stock Based Compensation is $1.01 Mil. Overall, CapsoVision has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does CapsoVision's Stock Based Compensation compare to OFIX and CATX?
CapsoVision's Stock Based Compensation of $1.01 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Medical Devices & Instruments company?
A good Stock Based Compensation depends on the Medical Devices & Instruments industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for CapsoVision and its competitors. CapsoVision's current Stock Based Compensation is $1.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CapsoVision stock overvalued right now?
CapsoVision (CV) has a current Stock Based Compensation of $1.01 Mil. The current Stock Based Compensation is $1.01 Mil. CapsoVision's overall GF Score™ is 10/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For CapsoVision (CV), the current Stock Based Compensation is $1.01 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CapsoVision Business Description

Other Exchanges H6U:Germany
Address 18805 Cox Avenue, Suite 250, Saratoga, CA, USA, 95070
CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. CapsoVision's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D, directed at the large intestines. Geographically, the company generates the majority of its revenue from the United States.
10GF Score

Get the complete analysis for CV

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.35
Price